ALZN
Price
$2.94
Change
-$0.06 (-2.00%)
Updated
Jul 3 closing price
Capitalization
2.35M
BPMUF
Price
$61.34
Change
+$3.64 (+6.31%)
Updated
Jul 1 closing price
Capitalization
728.91M
Interact to see
Advertisement

ALZN vs BPMUF

Header iconALZN vs BPMUF Comparison
Open Charts ALZN vs BPMUFBanner chart's image
Alzamend Neuro
Price$2.94
Change-$0.06 (-2.00%)
Volume$89.38K
Capitalization2.35M
Basilea Pharmaceutica AG
Price$61.34
Change+$3.64 (+6.31%)
Volume$7
Capitalization728.91M
ALZN vs BPMUF Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. BPMUF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Hold and BPMUF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ALZN: $2.94 vs. BPMUF: $61.34)
Brand notoriety: ALZN and BPMUF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 4% vs. BPMUF: 50%
Market capitalization -- ALZN: $2.35M vs. BPMUF: $728.91M
ALZN [@Biotechnology] is valued at $2.35M. BPMUF’s [@Biotechnology] market capitalization is $728.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileBPMUF’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • BPMUF’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALZN and BPMUF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 4 TA indicator(s) are bullish while BPMUF’s TA Score has 3 bullish TA indicator(s).

  • ALZN’s TA Score: 4 bullish, 3 bearish.
  • BPMUF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, both ALZN and BPMUF are a good buy in the short-term.

Price Growth

ALZN (@Biotechnology) experienced а +0.68% price change this week, while BPMUF (@Biotechnology) price change was +6.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ALZN is expected to report earnings on Mar 10, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMUF($729M) has a higher market cap than ALZN($2.36M). BPMUF YTD gains are higher at: 16.108 vs. ALZN (-71.839). ALZN has higher annual earnings (EBITDA): -4.16M vs. BPMUF (-4.5M). BPMUF has more cash in the bank: 63M vs. ALZN (3.36M). ALZN has less debt than BPMUF: ALZN (301K) vs BPMUF (112M). BPMUF has higher revenues than ALZN: BPMUF (149M) vs ALZN (0).
ALZNBPMUFALZN / BPMUF
Capitalization2.36M729M0%
EBITDA-4.16M-4.5M92%
Gain YTD-71.83916.108-446%
P/E RatioN/A8.32-
Revenue0149M-
Total Cash3.36M63M5%
Total Debt301K112M0%
FUNDAMENTALS RATINGS
BPMUF: Fundamental Ratings
BPMUF
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNBPMUF
RSI
ODDS (%)
Bullish Trend 4 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
19%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 2 days ago
24%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
15%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
11%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AILIX12.22N/A
N/A
Cavanal Hill Hedged Equity Income Instl
NBSLX51.58N/A
N/A
Neuberger Berman Sustainable Equity I
TSVIX28.40N/A
N/A
Transamerica Small/Mid Cap Value I
MSFKX19.80N/A
N/A
MFS Total Return R6
AATSX19.47N/A
N/A
Ancora/Thelen Small-Mid Cap S

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
-2.00%
SRPT - ALZN
49%
Loosely correlated
+0.25%
VRAX - ALZN
43%
Loosely correlated
-1.15%
SNSE - ALZN
41%
Loosely correlated
-2.54%
BPMUF - ALZN
36%
Loosely correlated
N/A
SILO - ALZN
33%
Loosely correlated
-2.15%
More

BPMUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMUF has been loosely correlated with AAVXF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMUF jumps, then AAVXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMUF
1D Price
Change %
BPMUF100%
N/A
AAVXF - BPMUF
47%
Loosely correlated
N/A
ABCZF - BPMUF
38%
Loosely correlated
N/A
ALZN - BPMUF
36%
Loosely correlated
-2.00%
GTBP - BPMUF
29%
Poorly correlated
-9.72%
NCNA - BPMUF
28%
Poorly correlated
-5.13%
More